... The agency in February enlisted India's Sun Pharmaceutical Industries to provide an alternate supply of Johnson & Johnson's ($JNJ) cancer drug Doxil. A shortage of Doxil was created when J&J's contract supplier Ben Venue Laboratories closed a plant in Ohio because of extensive manufacturing problems. The alternative treatment, Lipodox, is being imported from India in a "temporary, limited arrangement" until J&J can secure its own Doxil supplies. That effort has been successful enough that Johnson & Johnson earlier this month said it would be able to release some Doxil for clinical trials.
...